↓ Skip to main content

Cost effectiveness of a pentavalent rotavirus vaccine in Oman

Overview of attention for article published in BMC Infectious Diseases, June 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
47 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost effectiveness of a pentavalent rotavirus vaccine in Oman
Published in
BMC Infectious Diseases, June 2014
DOI 10.1186/1471-2334-14-334
Pubmed ID
Authors

Salah Thabit Al Awaidy, Berhanu G Gebremeskel, Idris Al Obeidani, Said Al Baqlani, Wisam Haddadin, Megan A O’Brien

Abstract

Rotavirus gastroenteritis (RGE) is the leading cause of diarrhea in young children in Oman, incurring substantial healthcare and economic burden. We propose to formally assess the potential cost effectiveness of implementing universal vaccination with a pentavalent rotavirus vaccine (RV5) on reducing the health care burden and costs associated with rotavirus gastroenteritis (RGE) in Oman

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Brazil 1 2%
Unknown 45 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 32%
Student > Master 10 21%
Student > Bachelor 4 9%
Student > Ph. D. Student 3 6%
Student > Postgraduate 2 4%
Other 3 6%
Unknown 10 21%
Readers by discipline Count As %
Medicine and Dentistry 12 26%
Economics, Econometrics and Finance 6 13%
Social Sciences 4 9%
Nursing and Health Professions 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Other 6 13%
Unknown 15 32%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 June 2014.
All research outputs
#2,284,916
of 4,507,778 outputs
Outputs from BMC Infectious Diseases
#1,256
of 2,509 outputs
Outputs of similar age
#52,128
of 107,716 outputs
Outputs of similar age from BMC Infectious Diseases
#101
of 164 outputs
Altmetric has tracked 4,507,778 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,509 research outputs from this source. They receive a mean Attention Score of 2.7. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 107,716 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 164 others from the same source and published within six weeks on either side of this one. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.